Description
Promote growth and development, strengthen physical fitness, and improve immunity; reduce the level of triglycerides in the blood and relieve fatigue; enhance appetite; improve calcium absorption and its accumulation in the body, treat and prevent osteoporosis, and accelerate bone growth; promote central nervous system development, improve insomnia, and improve memory; regulate sugar metabolism and prevent diabetes.
Details
Specification
| L-Lysine Hcl | CP2020 injection grade | EP11 | USP43 |
| Assay | ≥ 98.8% | 98.5-101.0% | 98.5-101.5% |
| PH | 5.0-6.0 | / | / |
| Specific rotation[a]D20 | +20.4°-+21.5° | +21.0°-+22.5° | +20.4°-+21.4° |
| Specific rotation[a]D25 | / | / | / |
| Transmittance(T430) | ≥ 98.5% | / | / |
| Appearance of solution | / | / | / |
| Chloride(Cl) | 19.0-19.6% | / | 19.0-19.6% |
| Ammonium(NH4) | ≤0.02% | ≤0.02% | / |
| Sulfate(SO4) | ≤0.02% | ≤0.03% | ≤0.03% |
| Iron(Fe) | ≤30PPM | ≤30PPM | ≤30PPM |
| Heavy metals(Pb) | ≤10PPM | / | ≤15PPM |
| Arsenic | ≤1PPM | / | / |
| Other amino acids | ≤0.5% | / | Individual impurities: ≤ 0.5% |
| Total impurities: ≤ 2.0% | |||
| Ninhydrin-positive substances | / | Each impurity≤ 0.2 % | / |
| Total impurities≤ 1.0% | |||
| Loss on drying | ≤0.40% | ≤0.50% | ≤0.40% |
| Residue on ignition | ≤0.10% | ≤0.10% | ≤0.10% |
| Total plate count | / | / | / |
| Moulds & Yeasts | / | / | / |
| Endotoxin | <10 EU/g | <10 EU/g |
